News
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.
Here’s another clue to who might be more vulnerable than others to long Covid. A new study published Wednesday in PLOS has ...
With COVID-19 subsiding and the public health emergency over, most people no longer dwell on the virus that so recently terrified the world. Yet millions are still forced to do so because of ...
6d
Green Matters on MSNCOVID-19 Vaccine Deemed Safe Long Term in New Study, Most Common Side Effects RevealedA half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...
The Trump administration is backing away from the Centers for Disease Control and Prevention (CDC) recommendations to ...
Policymakers and researchers quickly discovered a troubling pattern: Many deaths linked to the virus were never officially ...
Hosted on MSN12d
Moderna study shows immune response in older adults for a combo flu and COVID-19 shotA combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results